Business Context and Reporting Period
Company: Oramed Pharmaceuticals Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 9, 2010
Reporting Period: Event date of June 8, 2010
This filing serves as a Regulation FD disclosure regarding a corporate announcement made on June 8, 2010. The company is a biopharmaceutical entity incorporated in Nevada with principal executive offices in Jerusalem, Israel.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is a current event disclosure and does not contain financial statements or performance metrics.
Material Changes
No material financial changes or operational shifts are reported in this document. The filing solely discloses a scheduled corporate presentation.
Outlook, Management Commentary, and Risks
Management Commentary: The company announced that it was selected to present at the 9th National Life Science & Technology Week ILSI-BIOMED Conference in Israel 2010.
Event Details:
- Speaker: Nadav Kidron, Chief Executive Officer.
- Date: Wednesday, June 16, 2010.
- Time: 11:50 a.m. (IDT).
- Location: David Intercontinental Hotel, Tel-Aviv, Israel.
- Session: BioPharma Session.
Investor Verification Checklist
- Verify the content of the press release attached as Exhibit 99.1 for specific details on the presentation topic.
- Confirm the company's participation status at the ILSI-BIOMED Conference 2010.
- Review subsequent filings for any financial updates or clinical trial data that may have been presented at the conference.